Business
CSL confirms UQ vaccine production, trials set for December – Sydney Morning Herald
The blood plasma giant has sealed its deal with the Australian government, confirming it is ready to produce an Australian COVID-19 vaccine candidate if trials …
Blood plasma giant CSL has confirmed the deal with the Australian government to produce the University of Queensland’s COVID-19 vaccine has been sealed, with the next stage of trials planned to start in December.
The $132 billion biotech told investors on Thursday morning it had signed off on the final agreement to produce 51 million doses of the University of Queensland (UQ) vaccine , known as V451, if it is successful. It said first participants in the phase 2b/3 trials of the product would b…
-
Noosa News21 hours agoElectrify your vehicle, home or business at Noosa’s EV & Electrify Everything Expo
-
Noosa News19 hours agoQueensland plan to increase lethal shark control measures goes against advice of government-commissioned report
-
Noosa News16 hours agoAustralia’s newest rice mill funded largely by farmers
-
Business19 hours agoHow Australia’s most valuable company is using AI to compete